Could a tiny aspirin dose plus a blood thinner be safer for heart patients?

This study tested a new combination of very low-dose aspirin (20 mg twice daily) plus a blood thinner called rivaroxaban (2.5 mg twice daily) in 48 adults with chronic coronary syndromes. Researchers compared this new regimen to standard aspirin alone (75 mg once daily) and standard aspirin plus rivaroxaban. They measured bleeding time, blood clotting, and inflammation markers to see if the new combo might be safer and just as effective. The goal was to gather information, not to treat or cure the disease.